Head of GI Cancers, Global Marketing, Oncology Business Unit

Role Summary

Head of GI Cancers, Global Marketing, Oncology Business Unit. Based in Boston, MA, this role leads the global GI oncology asset strategy within Takeda Oncology, reporting to the VP, Head of Global Marketing. You will collaborate with a cross-functional, global team to drive an asset in the GI cancer space, shape the GI Disease Area Strategy and Brand Plan, and lead a high-performing team to deliver launch readiness, lifecycle management, and revenue growth.

Responsibilities

• Shape and influence global asset strategy through deep collaboration with R&D and Global Product Leaders, driving the development of the Clinical Development Program (CDP) and other critical asset components.
• Partner with senior leadership across functions, including the Global Product Team, to accelerate asset development and deliver on KPI’s and revenue targets.
• Lead execution of the global asset strategy, ensuring commercial launch readiness and alignment with Takeda Oncology’s overarching business objectives.
• Drive development of the GI Disease Area Strategy and Brand Plan, including branding elements, financial planning, forecasting, and life cycle management to maximize portfolio value.
• Inspire and lead a high-performing team of Global Brand and CDx Leads, fostering strategic excellence and flawless execution to achieve brand success and competitive differentiation.
• Set the strategic commercial direction for the GI oncology asset, driving portfolio optimization through validated growth opportunities, Life Cycle Management (LCM), and prioritized initiatives.
• Own enterprise-level launch readiness, ensuring governance alignment and flawless execution of pre-launch and launch activities.
• Lead insight-driven decision-making, converting market intelligence into a compelling brand narrative; leverage analytics to validate opportunities, optimize marketing mix, and maximize ROI on brand investments.
• Shape managed markets strategy to secure long-term brand value, partnering across internal and external stakeholders to deliver pricing, access, and reimbursement solutions.
• Drive LCM strategy to expand indications and sustain competitive advantage, proactively anticipating market dynamics and orchestrating cross-functional execution to maximize asset value.

Qualifications

• Required: Bachelor’s degree with 10+ years of progressive pharmaceutical experience in marketing or strategy, including exposure to both U.S. and ex-U.S. markets.
• Required: Proven oncology expertise, including in new product planning, and successful launch execution.
• Required: Deep oncology knowledge, market dynamics, brand/franchise management, and effective HCP engagement strategies.
• Required: 3–5+ years of leadership experience, with a track record of managing and developing high-performing teams.
• Required: Demonstrated P&L ownership and strong financial acumen, including forecasting and resource allocation.
• Required: Extensive experience in marketing strategy and execution, with the ability to communicate vision and influence internal stakeholders and external agencies.
• Required: Strong collaboration skills, partnering effectively across countries, functions, and senior leadership to drive asset development and revenue growth.
• Required: Proven ability to manage complexity and lead through change, demonstrating learning agility and adaptability.
• Required: Strategic decision-making capability, balancing business, financial, and risk considerations to deliver optimal outcomes.
• Required: Influential leadership, including situations without direct authority, to align stakeholders and drive results.
• Preferred: MBA and/or PhD
• Preferred: Experience in GI Cancers

Education

Skills